Short answer
Inhibrx Biosciences, Inc. (INBX) filed an 8-K current report with the SEC on February 23, 2026 reporting Item 7.01 (Regulation FD Disclosure). Updated corporate presentation posted Feb 23, 2026 to investor relations website and filed as Exhibit 99.1.
Inhibrx Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Updated corporate presentation posted Feb 23, 2026 to investor relations website and filed as Exhibit 99.1
- Presentation used for investor conferences/meetings: signals active investor outreach, likely contains pipeline or strategic updates
- Substantive content in Exhibit 99.1; filing itself contains no disclosed financial figures or specific operational data
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inhibrx Biosciences, Inc. 8-K filings
Get the next INBX 8-K as it lands
Follow INBX for push alerts, or ask the research agent what this filing means.